Trademark: 88427943
Status Date
Monday, April 12, 2021
Filing Date
Monday, May 13, 2019
Published for Opposition
Tuesday, July 16, 2019
Abandoned Date
Monday, April 12, 2021
5 Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
Apr 12, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Apr 12, 2021
Abandonment - No Use Statement Filed
Aug 15, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 13, 2020
Extension 2 Granted
Aug 13, 2020
Extension 2 Filed
Aug 13, 2020
Teas Extension Received
Feb 8, 2020
Notice Of Approval Of Extension Request E-Mailed
Feb 6, 2020
Extension 1 Granted
Feb 6, 2020
Extension 1 Filed
Feb 6, 2020
Teas Extension Received
Sep 10, 2019
Noa E-Mailed - Sou Required From Applicant
Jul 16, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 16, 2019
Published For Opposition
Jun 26, 2019
Notification Of Notice Of Publication E-Mailed
Jun 6, 2019
Approved For Pub - Principal Register
Jun 4, 2019
Assigned To Examiner
May 29, 2019
New Application Office Supplied Data Entered In Tram
May 16, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
